Edition:
United States

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

7.49USD
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
$7.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
172,452
52-wk High
$29.02
52-wk Low
$6.56

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 20 Aug 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 2 1 3
(3) HOLD 3 3 3 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.33 2.33 2.40 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 13.12 15.50 11.00 74.10
Quarter Ending Dec-18 6 12.61 15.50 10.68 104.10
Year Ending Dec-18 6 56.46 61.57 53.00 119.14
Year Ending Dec-19 6 68.55 86.25 43.00 73.14
Earnings (per share)
Quarter Ending Sep-18 6 -0.34 -0.27 -0.42 1.58
Quarter Ending Dec-18 6 -0.37 -0.27 -0.48 2.50
Year Ending Dec-18 6 -1.26 -1.08 -1.44 -0.19
Year Ending Dec-19 6 -1.22 -0.25 -2.33 -2.03

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 12.91 19.38 6.47 50.13
Quarter Ending Mar-18 15.11 11.19 3.92 25.92
Quarter Ending Dec-17 16.21 12.99 3.22 19.85
Quarter Ending Sep-17 20.00 18.08 1.92 9.62
Quarter Ending Jun-17 19.94 20.29 0.35 1.76

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 13.12 13.01 13.29 13.71 74.10
Quarter Ending Dec-18 12.61 12.61 13.83 14.36 104.10
Year Ending Dec-18 56.46 55.36 51.37 52.64 119.14
Year Ending Dec-19 68.55 68.69 67.53 72.03 73.14

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 1 0 2 1
Quarter Ending Dec-18 0 0 1 2
Year Ending Dec-18 1 0 5 0
Year Ending Dec-19 0 1 1 2
Earnings